The Fibrinolytic System in Peripartum Depression

Abstract

The relationship between depression and reduced fibrinolytic activity reflects the role of tissue plasminogen activator and plasmin in brain remodeling underlying resilience, depression remission, and reward processing, rather than the dissolution of fibrin clots. Individuals who experience depression demonstrate hippocampal and prefrontal cortex atrophy, as well as impaired neuronal connectivity. Brain-derived neurotrophic factor (BDNF), synthesized as a precursor that is activated through cleavage by tissue plasminogen activator and plasmin, influences adult neurogenesis and neuronal plasticity in the hippocampus and prefrontal cortex. Depression is associated with decreased brain levels of BDNF, due to reduced activity of tissue plasminogen activator and plasmin. Tissue plasminogen activator and plasmin also mediate the release of dopamine, a neurotransmitter implicated in motivation and reward. Peripartum depression defines a depressive episode that occurs during pregnancy or in the first month after delivery, reinforcing the concept that postpartum depression may be a continuum of antenatal depression. This article describes the fibrinolytic status in the healthy brain, in stress and depression, emphasizing the links between biological markers of depression and defective fibrinolysis. It also discusses the association between hypofibrinolysis and risk factors for perinatal depression, including polycystic ovary syndrome, early miscarriage, preeclampsia, stressful life events, sedentariness, eating habits, gestational and type 2 diabetes, and antithyroid peroxidase antibodies. In addition, it reviews the evidence that antidepressant medications and interventions as diverse as placebo, psychotherapy, massage, video game playing, regular exercise, dietary modifications, omega 3 fatty acid supplementation, neurohormones, and cigarette smoking may reduce depression by restoring the fibrinolytic activity. Last, it suggests new directions for research.

Keywords

adverse pregnancy outcomes - antidepressants - diet - exercise - lifestyle interventions - peripartum depression - risk factors - tissue plasminogen activator - videogame playing

Publication History

Article published online:
16 September 2022

• References

• 1 Cepeda MS, Kern DM, Nicholson S. Treatment resistant depression in women with peripartum depression. BMC Pregnancy Childbirth 2019; 19 (01) 323
• 2 Hoertel N, López S, Peyre H. et al. Are symptom features of depression during pregnancy, the postpartum period and outside the peripartum period distinct? Results from a nationally representative sample using item response theory (IRT). Depress Anxiety 2015; 32 (02) 129-140
• 3 Mangla K, Hoffman MC, Trumpff C, O'Grady S, Monk C. Maternal self-harm deaths: an unrecognized and preventable outcome. Am J Obstet Gynecol 2019; 221 (04) 295-303
• 4 Lindahl V, Pearson JL, Colpe L. Prevalence of suicidality during pregnancy and the postpartum. Arch Women Ment Health 2005; 8 (02) 77-87
• 5 Osborne S, Biaggi A, Chua TE. et al. Antenatal depression programs cortisol stress reactivity in offspring through increased maternal inflammation and cortisol in pregnancy: the Psychiatry Research and Motherhood - Depression (PRAM-D) Study. Psychoneuroendocrinology 2018; 98: 211-221
• 6 Waters CS, Hay DF, Simmonds JR, van Goozen SH. Antenatal depression and children's developmental outcomes: potential mechanisms and treatment options. Eur Child Adolesc Psychiatry 2014; 23 (10) 957-971
• 7 Underwood L, Waldie K, D'Souza S, Peterson ER, Morton S. A review of longitudinal studies on antenatal and postnatal depression. Arch Women Ment Health 2016; 19 (05) 711-720
• 8 Hoirisch-Clapauch S. Mechanisms affecting brain remodeling in depression: do all roads lead to impaired fibrinolysis?. Mol Psychiatry 2022; 27 (01) 525-533
• 9 Jiang H, Chen S, Li C. et al. The serum protein levels of the tPA-BDNF pathway are implicated in depression and antidepressant treatment. Transl Psychiatry 2017; 7 (04) e1079
• 10 Taliaz D, Loya A, Gersner R, Haramati S, Chen A, Zangen A. Resilience to chronic stress is mediated by hippocampal brain-derived neurotrophic factor. J Neurosci 2011; 31 (12) 4475-4483
• 11 McEwen BS. A life-course, epigenetic perspective on resilience in brain and body. In: Alon Chen. ed. Stress Resilience: Molecular and Behavioral Aspects. 2nd ed.. Academic Press; 2020: 1-21
• 12 Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci 2007; 10 (09) 1089-1093
• 13 Fung J, Gelaye B, Zhong QY. et al. Association of decreased serum brain-derived neurotrophic factor (BDNF) concentrations in early pregnancy with antepartum depression. BMC Psychiatry 2015; 15: 43
• 14 Gao X, Wang J, Yao H, Cai Y, Cheng R. Serum BDNF concentration after delivery is associated with development of postpartum depression: a 3-month follow up study. J Affect Disord 2016; 200: 25-30
• 15 Chow R, Wessels JM, Foster WG. Brain-derived neurotrophic factor (BDNF) expression and function in the mammalian reproductive tract. Hum Reprod Update 2020; 26 (04) 545-564
• 16 Rubin L, Stabler CT, Schumacher-Klinger A, Marcinkiewicz C, Lelkes PI, Lazarovici P. Neurotrophic factors and their receptors in lung development and implications in lung diseases. Cytokine Growth Factor Rev 2021; 59: 84-94
• 17 Heissig B, Hattori K, Friedrich M, Rafii S, Werb Z. Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases. Curr Opin Hematol 2003; 10 (02) 136-141
• 18 Tay CT, Teede HJ, Boyle JA, Kulkarni J, Loxton D, Joham AE. Perinatal mental health in women with polycystic ovary syndrome: a cross-sectional analysis of an Australian population-based cohort. J Clin Med 2019; 8 (12) 2070
• 19 Dachew BA, Scott JG, Alati R. Hypertensive disorders during pregnancy and perinatal mental health symptoms. J Affect Disord Rep 2021; 6: 100245
• 20 Bergink V, Laursen TM, Johannsen BM, Kushner SA, Meltzer-Brody S, Munk-Olsen T. Pre-eclampsia and first-onset postpartum psychiatric episodes: a Danish population-based cohort study. Psychol Med 2015; 45 (16) 3481-3489
• 21 Caropreso L, de Azevedo Cardoso T, Eltayebani M, Frey BN. Preeclampsia as a risk factor for postpartum depression and psychosis: a systematic review and meta-analysis. Arch Women Ment Health 2020; 23 (04) 493-505
• 22 Wang Y, Meng Z, Pei J. et al. Anxiety and depression are risk factors for recurrent pregnancy loss: a nested case-control study. Health Qual Life Outcomes 2021; 19 (01) 78
• 23 Hu R, Li Y, Zhang Z, Yan W. Antenatal depressive symptoms and the risk of preeclampsia or operative deliveries: a meta-analysis. PLoS One 2015; 10 (03) e0119018
• 24 Ghimire U, Papabathini SS, Kawuki J, Obore N, Musa TH. Depression during pregnancy and the risk of low birth weight, preterm birth and intrauterine growth restriction- an updated meta-analysis. Early Hum Dev 2021; 152: 105243
• 25 Hoirisch-Clapauch S, Brenner B. The role of the fibrinolytic system in female reproductive disorders and depression. Thromb Update 2020; 1: 100004
• 26 Yamamoto K, Takeshita K, Shimokawa T. et al. Plasminogen activator inhibitor-1 is a major stress-regulated gene: implications for stress-induced thrombosis in aged individuals. Proc Natl Acad Sci U S A 2002; 99 (02) 890-895
• 27 Wright N, Hill J, Pickles A, Sharp H. The specific role of relationship life events in the onset of depression during pregnancy and the postpartum. PLoS One 2015; 10 (12) e0144131
• 28 Liu CH, Erdei C, Mittal L. Risk factors for depression, anxiety, and PTSD symptoms in perinatal women during the COVID-19 Pandemic. Psychiatry Res 2021; 295: 113552
• 29 Emamian F, Khazaie H, Okun ML, Tahmasian M, Sepehry AA. Link between insomnia and perinatal depressive symptoms: a meta-analysis. J Sleep Res 2019; 28 (06) e12858
• 30 Guida J, Sundaram S, Leiferman J. Antenatal physical activity: investigating the effects on postpartum depression. Health 2012; 4: 25287
• 31 Knudsen JR, Steenberg DE, Hingst JR. et al. Prior exercise in humans redistributes intramuscular GLUT4 and enhances insulin-stimulated sarcolemmal and endosomal GLUT4 translocation. Mol Metab 2020; 39: 100998
• 32 Kang SY, Kim HB, Sunwoo S. Association between anemia and maternal depression: a systematic review and meta-analysis. J Psychiatr Res 2020; 122: 88-96
• 33 Molyneaux E, Poston L, Ashurst-Williams S, Howard LM. Obesity and mental disorders during pregnancy and postpartum: a systematic review and meta-analysis. Obstet Gynecol 2014; 123 (04) 857-867
• 34 Mitra M, Iezzoni LI, Zhang J, Long-Bellil LM, Smeltzer SC, Barton BA. Prevalence and risk factors for postpartum depression symptoms among women with disabilities. Matern Child Health J 2015; 19 (02) 362-372
• 35 Wurtman JJ, Wurtman RJ. Depression can beget obesity can beget depression. J Clin Psychiatry 2015; 76 (12) e1619-e1621
• 36 Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012; 489 (7415): 242-249
• 37 Castro MC, Massa ML, Arbeláez LG, Schinella G, Gagliardino JJ, Francini F. Fructose-induced inflammation, insulin resistance and oxidative stress: a liver pathological triad effectively disrupted by lipoic acid. Life Sci 2015; 137: 1-6
• 38 Wilson CA, Newham J, Rankin J. et al. Is there an increased risk of perinatal mental disorder in women with gestational diabetes? A systematic review and meta-analysis. Diabet Med 2020; 37 (04) 602-622
• 39 Jovanovič L, Liang Y, Weng W, Hamilton M, Chen L, Wintfeld N. Trends in the incidence of diabetes, its clinical sequelae, and associated costs in pregnancy. Diabetes Metab Res Rev 2015; 31 (07) 707-716
• 40 Minaldi E, D'Andrea S, Castellini C. et al. Thyroid autoimmunity and risk of post-partum depression: a systematic review and meta-analysis of longitudinal studies. J Endocrinol Invest 2020; 43 (03) 271-277
• 41 Farid NR, Griffiths BL, Collins JR, Marshall WH, Ingram DW. Blood coagulation and fibrinolysis in thyroid disease. Thromb Haemost 1976; 35 (02) 415-422
• 42 Liu J, Duan Y, Fu J, Wang G. Association between thyroid hormones, thyroid antibodies, and cardiometabolic factors in non-obese individuals with normal thyroid function. Front Endocrinol (Lausanne) 2018; 9: 130
• 43 Czarzasta K, Makowska-Zubrycka M, Kasarello K. et al. A rat model to study maternal depression during pregnancy and postpartum periods, its comorbidity with cardiovascular diseases and neurodevelopmental impact in the offspring. Physiol Behav 2019; 199: 258-264
• 44 Previti G, Pawlby S, Chowdhury S, Aguglia E, Pariante CM. Neurodevelopmental outcome for offspring of women treated for antenatal depression: a systematic review. Arch Women Ment Health 2014; 17 (06) 471-483
• 45 Hoirisch-Clapauch S, Nardi AE. Autism spectrum disorders: let's talk about glucose?. Transl Psychiatry 2019; 9 (01) 51
• 46 Ishikawa T, Obara T, Kikuchi S. et al. Antidepressant prescriptions for prenatal and postpartum women in Japan: a health administrative database study. J Affect Disord 2020; 264: 295-303
• 47 Stewart D, Vigod S. Antenatal use of antidepressants and risk of teratogenicity and adverse pregnancy outcomes: selective serotonin reuptake inhibitors (SSRIs). Up To Date 2018
• 48 Molenaar NM, Bais B, Lambregtse-van den Berg MP. et al. The international prevalence of antidepressant use before, during, and after pregnancy: a systematic review and meta-analysis of timing, type of prescriptions and geographical variability. J Affect Disord 2020; 264: 82-89
• 49 Geiser F, Conrad R, Imbierowicz K. et al. Coagulation activation and fibrinolysis impairment are reduced in patients with anxiety and depression when medicated with serotonergic antidepressants. Psychiatry Clin Neurosci 2011; 65 (05) 518-525
• 50 Meltzer-Brody S, Kanes SJ. Allopregnanolone in postpartum depression: role in pathophysiology and treatment. Neurobiol Stress 2020; 12: 100212
• 51 Almeida FB, Nin MS, Barros HMT. The role of allopregnanolone in depressive-like behaviors: focus on neurotrophic proteins. Neurobiol Stress 2020; 12: 100218
• 52 Hallbäck I, Hägg S, Eriksson AC, Whiss PA. In vitro effects of serotonin and noradrenaline reuptake inhibitors on human platelet adhesion and coagulation. Pharmacol Rep 2012; 64 (04) 979-983
• 53 McCloskey DJ, Postolache TT, Vittone BJ. et al. Selective serotonin reuptake inhibitors: measurement of effect on platelet function. Transl Res 2008; 151 (03) 168-172
• 54 Tseng YL, Chiang ML, Huang TF, Su KP, Lane HY, Lai YC. A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation. Thromb Res 2010; 126 (06) 517-523
• 55 Clark JC, Damaskinaki FN, Cheung YFH, Slater A, Watson SP. Structure-function relationship of the platelet glycoprotein VI (GPVI) receptor: does it matter if it is a dimer or monomer?. Platelets 2021; 32 (06) 724-732
• 56 Roose SP, Rutherford BR. Selective serotonin reuptake inhibitors and operative bleeding risk: a review of the literature. J Clin Psychopharmacol 2016; 36 (06) 704-709
• 57 Jiang HY, Xu LL, Li YC, Deng M, Peng CT, Ruan B. Antidepressant use during pregnancy and risk of postpartum hemorrhage: a systematic review and meta-analysis. J Psychiatr Res 2016; 83: 160-167
• 58 Brunner S, Camboni D, Flörchinger B. et al. Patients under antidepressants undergoing cardiac surgery have a high risk for adverse events. Thorac Cardiovasc Surg 2013; 61: OP156
• 59 Lycke KD, Christiansen CF, Lund JL, Iversen LH, Nørgaard M. Preadmission use of antidepressants and risk of complications and death after colorectal cancer surgery: a nationwide population-based cohort study. Colorectal Dis 2019; 21 (06) 651-662
• 60 Cox EQ, Sowa NA, Meltzer-Brody SE, Gaynes BN. The perinatal depression treatment cascade: baby steps toward improving outcomes. J Clin Psychiatry 2016; 77 (09) 1189-1200
• 61 Nyfløt LT, Sandven I, Stray-Pedersen B. et al. Risk factors for severe postpartum hemorrhage: a case-control study. BMC Pregnancy Childbirth 2017; 17 (01) 17
• 62 Wisner KL, Stika CS, Ciolino JD. The first food and drug administration–indicated drug for postpartum depression—Brexanolone. JAMA Psychiatry 2019; 76 (10) 1001-1002
• 63 Li C, Sun X, Li Q, Sun Q, Wu B, Duan D. Role of psychotherapy on antenatal depression, anxiety, and maternal quality of life: a meta-analysis. Medicine (Baltimore) 2020; 99 (27) e20947
• 64 Hall HG, Cant R, Munk N. et al. The effectiveness of massage for reducing pregnant women's anxiety and depression; systematic review and meta-analysis. Midwifery 2020; 90: 102818
• 65 Ito M, Nagai T, Kamei H. et al. Involvement of tissue plasminogen activator-plasmin system in depolarization-evoked dopamine release in the nucleus accumbens of mice. Mol Pharmacol 2006; 70 (05) 1720-1725
• 66 Kołomańska-Bogucka D, Mazur-Bialy AI. Physical activity and the occurrence of postnatal depression—a systematic review. Medicina (Kaunas) 2019; 55 (09) 560
• 67 El-Sayed MS, Sale C, Jones PG, Chester M. Blood hemostasis in exercise and training. Med Sci Sports Exerc 2000; 32 (05) 918-925
• 68 ACOG Committee Opinion, Number 804. Physical activity and exercise during pregnancy and the postpartum period. Obstet Gynecol 2020; 135 (04) e178-e188
• 69 Abdollahi S, Soltani S, de Souza RJ, Forbes SC, Toupchian O, Salehi-Abargouei A. Associations between maternal dietary patterns and perinatal outcomes: a systematic review and meta-analysis of cohort studies. Adv Nutr 2021; 12 (04) 1332-1352
• 70 Zhang MM, Zou Y, Li SM. et al. The efficacy and safety of omega-3 fatty acids on depressive symptoms in perinatal women: a meta-analysis of randomized placebo-controlled trials. Transl Psychiatry 2020; 10 (01) 193
• 71 Mehta J, Lawson D, Saldeen TJ. Reduction in plasminogen activator inhibitor-1 (PAI-1) with omega-3 polyunsaturated fatty acid (PUFA) intake. Am Heart J 1988; 116 (5, Pt 1): 1201-1206
• 72 Li K, Huang T, Zheng J, Wu K, Li D. Effect of marine-derived n-3 polyunsaturated fatty acids on C-reactive protein, interleukin 6 and tumor necrosis factor α: a meta-analysis. PLoS One 2014; 9 (02) e88103
• 73 VanLandingham JW, Cekic M, Cutler SM. et al. Progesterone and its metabolite allopregnanolone differentially regulate hemostatic proteins after traumatic brain injury. J Cereb Blood Flow Metab 2008; 28 (11) 1786-1794
• 74 Shirayama Y, Fujita Y, Oda Y, Iwata M, Muneoka K, Hashimoto K. Allopregnanolone induces antidepressant-like effects through BDNF-TrkB signaling independent from AMPA receptor activation in a rat learned helplessness model of depression. Behav Brain Res 2020; 390: 112670
• 75 Krist AH, Davidson KW, Mangione CM. et al; US Preventive Services Task Force. Interventions for tobacco smoking cessation in adults, including pregnant persons: us preventive services task force recommendation statement. JAMA 2021; 325 (03) 265-279
• 76 Nagai T, Nabeshima T, Yamada K. Basic and translational research on proteinase-activated receptors: regulation of nicotine reward by the tissue plasminogen activator (tPA) - plasmin system via proteinase-activated receptor 1. J Pharmacol Sci 2008; 108 (04) 408-414
• 77 Shea AK, Steiner M. Cigarette smoking during pregnancy. Nicotine Tob Res 2008; 10 (02) 267-278
• 78 Crofts CA, Zinn C, Wheldon MC, Schofield GM. Hyperinsulinemia: best management practice. Diabesity 2016; 2: 1-11